Protein neddylation as a therapeutic target: challenges and opportunities
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci206924 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Shizhen Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute and. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Pyrimidines, Ubiquitins, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Protein neddylation is an evolutionarily conserved posttranslational modification that conjugates NEDD8 to its substrate, catalyzed by an E1-activating enzyme, E2-conjugating enzyme, and E3 ligase. Neddylation is essential for cellular homeostasis, and its dysregulation has been implicated in diverse human diseases, including cancer, neurodegenerative diseases, and metabolic disorders, making the process a promising therapeutic target. In this Review, we systematically summarize the biochemical activity and biological functions of neddylation; its alterations in human diseases, particularly in cancers; and its validation as an attractive target for cancer therapy. We provide an overview on the discovery of neddylation inhibitors and the progress of MLN4924 (pevonedistat) and TAS4464 clinical trials and critically evaluate the core challenges and emerging opportunities for therapeutic strategies targeting neddylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Institute and.
- Department of Breast Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Zhejiang Key Laboratory of Particle Radiotherapy Equipment, Hangzhou, China.
- Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang University Cancer Center, Hangzhou, China.
- Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, China.
Zitieren
APA
Zhang, S., Lan, H., & Sun, Y. (2026). Protein neddylation as a therapeutic target: challenges and opportunities. Journal of Clinical Investigation. https://doi.org/10.1172/jci206924
Vancouver
Zhang S, Lan H, Sun Y. Protein neddylation as a therapeutic target: challenges and opportunities. Journal of Clinical Investigation. 2026. doi:10.1172/jci206924
BibTeX
@article{Zhang2026,
author = {Zhang, Shizhen and Lan, Huiyin and Sun, Yi},
title = {Protein neddylation as a therapeutic target: challenges and opportunities},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci206924}
}
EUVIMED